Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03566888 · ClinicalTrials.gov registry record
Validation of a Noninvasive Automated Blood Pressure Device
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 85
- Enrollment target
NCT03566888: Completed study, sponsored by University of Southern California.
NCT03566888 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03566888 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
Study Summary
The investigator's objective is to validate the novel automated blood pressure device against the requirements set forth in the AAMI\_ISO 81060-2:2010 standard in voluntarily consented study participants.
Primary Outcome
Mean value of the differences of the paired (i.e., device under test - reference method) determinations for all study participants shall be within or equal to ± 5 mmHg with a standard deviation no greater than 8 mmHg (criterion 1). Standard deviation of the averaged paired determinations per participant shall meet the criterion 2 listed in the standard.
Interventions
- DEVICE Blood pressure assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2018-10-02 |
What the finished NCT03566888 record still lists
NCT03566888 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood pressure assessment is the first listed.
NCT03566888 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03566888 about?
NCT03566888 is a clinical study titled "Validation of a Noninvasive Automated Blood Pressure Device". The investigator's objective is to validate the novel automated blood pressure device against the requirements set forth in the AAMI\_ISO 81060-2:2010 standard in voluntarily consented study participants.
What is the current status of trial NCT03566888?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2017-08-01. Estimated completion is 2018-10-02.
What interventions are being tested in trial NCT03566888?
The interventions under investigation include: Blood pressure assessment (DEVICE).
Who is sponsoring clinical trial NCT03566888?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI